Drug Database
Back to search

Switzerland· 63119003

Ibandronat Spirig HC 150 mg Monatstabletten, Filmtabletten

A ibandronic acid product containing acidum ibandronicum, registered in Switzerland by Spirig HealthCare AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC M05BA06

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedIbandronat Spirig HC 150 mg Monatstab…ATCM05BA06REGISTER NO.63119003PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acidum ibandronicumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ibandronic acid is registered in 16 of 19 countries.

Countries holding a registration under ATC M05BA06 (ibandronic acid), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 10 of them publish a price we can compare per daily dose
Search ibandronic acid products by name

Ibandronic acid · ATC M05BA06

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ibandronic acid costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.089 in United States to $1.30 in Switzerland — a ×15 gap.

  • Switzerland: $1.30 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Ibandronic acid · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.30
  • ES Spain$0.49
  • IT Italy$0.38
  • US United States$0.089 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
acidum ibandronicum
Manufacturer
Spirig HealthCare AG
Country
Switzerland (CH)
ATC code
M05BA06
ATC class
Ibandronic acid
Defined daily dose
5 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680631190030
    Blist 1 Stk
    CHF 32.3

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

228 interactions on record for ibandronic acid.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ibandronic acid against other medicinesHow interaction checks work

Ibandronic acid · interactions on record

228 records

  • 12 severe
  • 98 moderate
  • 94 info

Most severe, free to view

  • EtelcalcetideH05BX04severe
  • SirolimusL01EG04severe
  • SirolimusL04AA10severe
  • TacrolimusL04AD02severe

24 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ibandronic acid in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ibandronic acid products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ibandronsäure Ratiopharm, Ibandronsäure Sandoz
  • Belgium · Ibandronate Eg
  • Bulgaria · Ибандронова Киселина Синтон, Ибандронова Киселина Стада
  • Czechia · Gerousia, Ikametin
  • Germany · Ibandronate Bluefish, Ibandronsäure Al
  • Denmark · Baxogar, Ibamyl
  • Estonia · Bonefurbit, Ibandronic Acid Synthon
  • Spain · Abrion, Ácido Ibandrónico Alter
  • Finland · Clastec, Ibandronat Stada
  • United Kingdom (Northern Ireland) · Bondronat, Ibandronic Acid
  • Greece · Axibal, Ibanate
  • Croatia · Bonnedra, Bonosta
  • Hungary · Ibandronate Pharmacenter, Ibandronsav Stada
  • Ireland · Ibandronic Acid Accord Healthcare Ireland, Ibandronic Acid Clonmel
  • Iceland · Ibandronic Acid Accord, Ibandronic Acid Alvogen
  • Italy · Acido Ibandronico Alter, Acido Ibandronico Aurobindo
  • Liechtenstein · Ibandronic Acid Accord, Ibandronic Acid Teva
  • Lithuania · Bonefurbit, Ibandronic Acid Ingen Pharma
  • Luxembourg · Ibandronate Eg
  • Latvia · Ibandronic Acid Ratiopharm, Ibandronic Acid Synthon
  • Malta · Ibandronic Acid Aurobindo
  • Netherlands · Baxogar, Ibandronic Acid Aurobindo
  • Norway · Axibal, Bonefurbit
  • Poland · Ibandronic Acid Aurovitas, Ibandronic Acid Synthon
  • Portugal · Ácido Ibandrónico Alter, Ácido Ibandrónico Aurobindo
  • Romania · Acid Ibandronic Stada
  • Sweden · Ibandronat Stada
  • Slovenia · Ibandronska Kislina Synthon
  • Slovakia · Gerousia, Ibandronic Acid Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eed474b8-013b-4129-ba3b-9ad4a05edaef
GET /v1/drugs/eed474b8-013b-4129-ba3b-9ad4a05edaef?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "acidum ibandronicum 150 mg",
  "valid_from": "2019-07-01",
  "limitations": "[{\"description\":\"Zur Behandlung von dokumentierter Osteoporose.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-10-01\"}]",
  "galenic_form": "Filmtabl 150 mg Monatstabl",
  "therapeutic_area": null,
  "sl_inclusion_date": "2013-06-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about ibandronic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console